NC
SYNH

Nicholas Company’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Nicholas Company’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-114,085
Closed -$4.18M – 227
2022
Q4 		$4.18M Hold
114,085
– – 0.09% 200
2022
Q3 		$5.38M Hold
114,085
– – 0.12% 174
2022
Q2 		$8.18M Buy
114,085
+145
+0.1% +$10.6K 0.18% 133
2022
Q1 		$9.22M Sell
113,940
-1,200
-1% -$102K 0.16% 140
2021
Q4 		$11.8M Buy
115,140
+15
+0% +$1.44K 0.19% 124
2021
Q3 		$10.1M Sell
115,125
-195
-0.2% -$17.7K 0.18% 130
2021
Q2 		$10.3M Buy
115,320
+45
+0% +$3.8K 0.18% 127
2021
Q1 		$8.74M Buy
115,275
+3,480
+3% +$262K 0.16% 150
2020
Q4 		$7.62M Sell
111,795
-560
-0.5% -$34.9K 0.14% 168
2020
Q3 		$5.97M Sell
112,355
-475
-0.4% -$28.3K 0.13% 170
2020
Q2 		$6.57M Sell
112,830
-1,385
-1% -$74.4K 0.15% 152
2020
Q1 		$4.5M Buy
114,215
+2,670
+2% +$156K 0.13% 169
2019
Q4 		$6.63M Buy
111,545
+3,360
+3% +$181K 0.14% 164
2019
Q3 		$5.76M Sell
108,185
-1,315
-1% -$67.5K 0.13% 171
2019
Q2 		$5.59M Sell
109,500
-2,565
-2% -$119K 0.12% 178
2019
Q1 		$5.8M Sell
112,065
-1,000
-0.9% -$48.5K 0.14% 164
2018
Q4 		$4.45M Hold
113,065
– – 0.12% 188
2018
Q3 		$5.83M Hold
113,065
– – 0.13% 184
2018
Q2 		$5.3M Buy
113,065
+30,410
+37% +$1.26M 0.12% 180
2018
Q1 		$2.93M Sell
82,655
-7,200
-8% -$282K 0.07% 203
2017
Q4 		$3.92M Sell
89,855
-24,430
-21% -$1.14M 0.09% 196
2017
Q3 		$5.98M Sell
114,285
-10,695
-9% -$596K 0.13% 144
2017
Q2 		$7.31M Sell
124,980
-300
-0.2% -$15.6K 0.16% 119
2017
Q1 		$5.74M Buy
125,280
+8,600
+7% +$428K 0.13% 137
2016
Q4 		$6.14M Buy
116,680
+445
+0.4% +$21.5K 0.14% 131
2016
Q3 		$5.18M Buy
116,235
+20,330
+21% +$882K 0.11% 139
2016
Q2 		$3.66M Buy
95,905
+10,700
+13% +$470K 0.07% 161
2016
Q1 		$3.51M Buy
+85,205
New +$3.51M 0.07% 161

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Nicholas Company's SYNH Position: Q1 2023 in Review

Nicholas Company sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 114,085 shares — an estimated $4.18M sold.

Nicholas Company first reported a position in SYNH in Q1 2016 and held it in 28 quarters. The position peaked at $11.8M in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Nicholas Company reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Nicholas Company sold 114,085 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $4.18M.
  • Nicholas Company first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 28 quarters.
  • Nicholas Company's Syneos Health, Inc. Class A Common Stock position peaked at $11.8M in Q4 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Nicholas Company's 13F filing for Q1 2023, filed 11 May 2023.